NIH FY2022 Funding and Success Rate Data for enacted appropriations was released. NIH spent $33.3 billion (of $45.2 billion total appropriation) for competing and noncompeting grant awards, a 3.1% increase ($1.02 billion) over the previous year. This includes monies for grants and Other Transaction awards and excludes research and development contracts.
In FY2022, 1,576 additional new and renewed extramural grants in FY 2022, for a total of 58,368 competing and non-competing awards (2.8% more than FY 2021). Fewer RPG applications were received in FY2022 and more awards were made, resulting in a higher success rate for new research project grants (RPGs), up to 20.7% in FY2022 from 19.1% in FY 2021.
Since most RPGs are R01-equivalent grants, the results of R01-equivalent grants showed similar patterns. NIH spent $19.1 billion on average on R01-equivalent grants in FY 2022 compared to $18.1 billion spent in FY 2021(5.4% increase). Also similar to RPGs, the R01-equivalent grant success rate increased to 21.6% in FY2022, up from 20.1% in FY 2021. Average costs spent on R01-equivalents in FY 2022 were $585,307 compared to $571,561 in FY 2021.
It’s important to note that spending for special appropriations for coronavirus are not included in this report. They can be found via RePORTER’s advanced search feature.
The full FY2022 funding & success rate data is here: https://bit.ly/3KKiMcs
